• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Cadence Pharmaceuticals

Anonymous board for Cadence Pharmaceuticals
Replies
3
Views
2K
Anonymous
Replies
4
Views
1K
Anonymous
Replies
0
Views
859
Anonymous
Replies
0
Views
1K
Anonymous
Replies
1
Views
1K
Anonymous
Replies
0
Views
855
Anonymous
Replies
2
Views
1K
Anonymous
Replies
13
Views
4K
Anonymous
Replies
2
Views
2K
Anonymous